A 28-month-old Negro male with atypical Sandhoff's disease (GM2 gangliosidosis, type 2) is described. Clinical presentation closely resembled Sandhoff's disease. The appendiceal neuron cytoplasm was distended with periodic acid-Schiff (PAS)-positive material. Hepatic glycolipid N-acetylneuraminic acid was elevated 1.5-fold, chiefly because of increased GM2. Neutral glycolipid hexose was elevated twofold, mainly because of a component with globoside-like chromatographic properties. Unlike patients with Sandhops disease, the child had total 0-D-N-acetylhexosaminidase activity 20-24% of normal in serum and plasma and 7-1 1% of normal in leukocytes and cultured fibroblasts, but activity in liver (<2y0 of normal) was similar to that in Sandhoff's disease. In all tissues examined, >95% of the activity was heat denaturable, corresponding in electrophoretic mobility to the heat-denaturable component of normal tissues. The decrease in heat-denaturable activity with time and the pH optimum were similar in patient and control crude tissue preparations and partially purified preparations of plasma hexosaminidase A. In the child's mother, total hexosaminidase activity was approximately 50y0 of mean control values in serum, plasma, and leukocytes, and serum hexosaminidase A was relatively increased. This finding, together with the death of at least three other children in the kindred from an apparently phenotypically similar illness, indicates the inherited nature of the disorder.
Introduction
minidase A is nearly absent in Tay-Sachs disease [22] Three genetic diseases are characterized by the accuand is reduced in the juvenile form [33] . Although mulation of ganglioside GM,: Tay-Sachs disease (GM, Sandhoff's disease is referred to as the "absent hexosagangli~sido~is, type I ) , Sandhoff's disease (type 2), and some ( < l o % of juvenile Gi\;l, gangliosidosis (type 3) [20, 473. All are has been detected in all tissues examined, predomievidenced by a defect in one or both of the A and B nantly as a component similar to hexosaminidase A forms of p-D-N-acetylhexosaminidase activity; hexosa- [12, 21, 29, 31, 391 . In both Tay-Sachs and Sandhoff's diseases, the brain contains 100-300 times normal amounts of ganglioside GM,; in Sandhoff's disease the visceral organs, also, contain abnormal amounts of asia10 GM, and globoside [21, 29, 391 . Recently we studied a case of what appears to be a variant of Sandhoff's disease, in that the hexosaminidase A levels in serum and plasma, and to a lesser extent in leukocytes and cultured fibroblasts, are higher than in other reported cases.
Case Report T h e patient, a Negro male, was 28 months old when referred for consultation. Development was considered to have been normal in the 1st year, but then his achievements plateaued. From age 20 months he appeared to regress slowly, stumbling easily, feeding poorly, drooling, and becoming less able to communicate. Brief akinetic seizures, noted at 23 months, were unrelated to fever and were controlled by phenobarbital, 60 mg/24 hr in divided doses.
T h e boy was handsome, but he drooled and his behavior was that of a 9-12-month-old. Height was 91 cm, weight 13.5 kg, and head circumference 52 cm. T h e retinal maculae contained areas of degeneration surrounded by pale haloes, and the optic discs were pale. Deep tendon reflexes and plantar responses were normal, and no excessive startle response was observed. T h e muscle was of decreased bulk and moderately hypotonic, the joints were lax, and there were small bilateral inguinal herniae and an umbilical hernia. His liver and spleen were not enlarged.
T h e llemogram was consistently normal, and no vacuolated leukocytes were demonstrable on smears. Serum electrolyte, creatine phosphokinase, and serum glutamic pyruvic transaminase values were normal, but serum glutamic oxaloacetic transaminase was 152 U (normal, 0-45) and lactic dehydrogenase (LDH) was 1,164 U (normal, 250-500) 1100 ml, with slight increases in LDH isoenzymes 1 and 2. Amino acid chromatography of the urine showed slightly increased carnosine and phosphoethanolamine, and examination for acid mucopolysaccharides [7] revealed increased uronic acid in the material precipitable by cetylpyridinium chloride (patient, 6.6 mg/24 hr; control subjects, mean 2.9 * 0.03 SEM). T h i n layer chromatography (TLC) of the cetylpyridinium chloride-precipitable material showed a minor component with chromatographic mobility similar to that of chondroitin sulfate, and a major component, staining purple with ortho-toluidine blue, with mobility slower than that of chondroitin sulfate or heparin.
Roentgenographic skeletal survey was normal. T h e EEG showed generalized paroxysmal activity during sleep, with well preserved background rhythms.
Samples of liver, muscle, and appendix were obtained at laparotomy, and of skin and sural nerve at biopsy. Both frozen and fixed specimens of liver, muscle, and sural nerve were histologically normal; in particular, the liver contained no storage cells and the Kupffer cells appeared normal. In the appendix, the cytoplasm of ganglion cells in both the Meissner and the Auerbach plexuses was greatly distended and it stained intensely with PAS in cryostat-cut sections.
T h e child's father was recently (accidentally) deceased. His mother, who was in good health, had been adopted; her adoptive parents stated that she was indirectly related to her husband but that they did not know the exact relation. In 1966, one of us (JT) diagnosed amaurotic familial idiocy in a female paternal cousin, then aged 16 months, who had evidenced developmental deterioration from the age of 9 months. SlVhen seen by J T she had optic atrophy and rusty brown pigmentation of the retinal maculae; ganglion cells and neurons of rectal and brain biopsy contained accumulated material with the staining characteristics of a ganglioside. Two of this cousin's eight siblings, and another child in the same deme, had had a similar clinical picture; their condition had deteriorated progressively and all had died between 3 and 4 years of age.
iMatel-ials and Methods
Serum was obtained once and plasma and leukocytes three times over the 4-month period of study. One sample of plasma and one of leukocytes were obtained and liver biopsy was performed when the patient had had no anticonvulsant therapy for 1 week. T h e mother gave informed consent for all of the investigations.
Serum was obtained from freshly collected blood clotted at 4" for 30 min, and plasma from the supernatant fraction of the leukocyte isolation. Preliminary studies indicated no difference in hexosaminidase activity in plasma thus obtained and in heparinized blood. Leukocytes were isolated by sedimentation in dextran [I] , subjected to osmotic shock [38] , frozen and thawed seven times, and sedimented at 3,000 x g for 10 min; the supernatant fraction was used. Tissues were frozen immediately and were held at -20" 11ntil analyzed.
T h e primary cell culture of fibroblast-like cells (called fibroblasts) was obtained from fragments of leg skin (explants) and cultured in Eagle's minimal essential diploid medium containing 10% fetal calf serum [4] ; monolayers were maintained by adding 5% fetal calf serum and 5% calf serum. When the monolayers were confluent, the cells were harvested by trypsinization and were washed three times with Eagle's minimal essential diploid medium. Control fibroblast cells were obtained similarly from cultures of neonatal human foreskins. Cell homogenates were prepared for measurement of hexosaminidase activity (details under Results).
Total lipids were extracted from liver tissue by repeated homogenization in chloroform-methanol (211, 211, 112; v/v); the pooled extracts were evaporated to dryness under N2, taken up in chloroform-methanol, 211, and washed [5] . For the upper phase, total glycolipid N-acetylneuraminic acid [17, 401 and individual ganglioside proportions [16] were determined, using mixed bovine brain ganglioside and GM, and GM, gangliosides [49] as standards. For the lower phase, cholesterol [2] , glycolipid hexose [9] , and phospholipid patterns [24, 281 were determined; neutral glycolipids were isolated by silicic acid chromatography and were separated into individual components by TLC [41] . Reference glycolipids were obtained by acid hydrolysis of mixed brain gangliosides [13] , and characterized by T L C followed by gas-liquid chromatography [41] . p-D-N-Acetylhexosaminidase A was partially purified [44] from the patient's and normal plasma, by salt fractionation and DEAE-Sephadex chromatography [50] . p-D-N-Acetylhexosaminidase activity was measured [22] with 4-methylumbellileryl (4-MU) derivatives of p-D-N-acetylglucosaminide (GlcNAc) or p-D-N-acetylgalactosaminide (GalNAc) [51] , and protein was determined by the method of Lowry et al. [15] . CelIuIose acetate electrophoresis [52] was performed at 0-4O in 0.02 M citrate phosphate buffer, pH 6.0 or 7.0, for 1.5 hr at 2.5-3.0 malstrip. Enzyme activity was located by incubating the strips with 1 mM 4-MU-GlcNAc in citrate phosphate buffer (0.04 M, p H 4.4) at 37" for 30 min [14] .
Results

Hepatic Lipid Analysis
Only 500 mg frozen tissue was available for chemical analysis. Compared with control samples stored for longer periods under identical conditions, the dry weight of the patient's liver tissue was increased (Table I); less than a quarter of the increase could be accounted for by chloroform-methanol-soluble lipid material. Neutral glycolipid hexose was increased, total phospholipids were slightly elevated, and cholesterol and cholesterol esters were within normal range. Apart from lysolecithin, which was elevated almost twofold, individual phospholipids were only slightly (<5%) affected: sphingomyelin and lecithin were slightly increased, and phosphatidyl serine and ethanolamine slightly decreased. Glycolipid N-acetylneuraminic acid was increased 1.5-fold (Table II) , mainly because of increased amounts of a ganglioside with chromatographic properties similar to those of GM,. GM,, and, to a lesser extent, the minor polysialogangliosides, were increased; but GM,, normally the major hepatic ganglioside, was decreased. T L C of the neutral glycolipid fraction after silicic acid chromatography showed a major increase in a component with mobility similar to that of globoside (N-acetylgalactosaminylgalactosylgalactosylglucosyl ceramide), and an apparently incompletely separated material, above the globoside spot, that might represent asialo GM2 (Fig. 1 ).
(The ceramide tetrahexoside formed by acid hydrolysis of gangliosides, which is a different species from globoqide. had a lower chromatographic mobility; see also Rderence 39.) Unfortunately, the small amounts of material available precluded further glycolipid characterization.
Enzyme Assay
Two of the control subjects from whom plasma was obtained were Negro children (one male, one female) aged 1 year. T h e patient's total serum hexosaminidase activity was 24% of mean control levels; >95% of this was the A fraction as determined by heat denaturation (Table 111) . (The serum hexosaminidase activity of a patient with Tay-Sachs disease was unaffected by heat denaturation in these experiments.) Further, on cellu- lose acetate electrophoresis, the major band of activity migrated the same as the heat-denaturable band in normal serum; only a faint trace of activity was observed in the heat-stable (hexosaminidase B) area (Fig.  2) . Plasma activity was 20% of control level, predominantly (>95%) hexosaminidase A (Table III) , and its electrophoretic mobility (not shown) was similar to that of serum. Leukocyte hexosaminidase activity in frozenlthawed leukocytes, which averaged 10% of mean control values, was >95% heat denaturable. On electrophoresis it corresponded to the two fast control bands; the fastest migrating and a portion of the second control band disappeared during heat denaturation (Fig. 2 ). Plasma and leukocyte activities were unchanged in the sample taken at the end of the n o medication period. T h e patient's nonfrozen homogenized leukocytes, with and without bovine serum albumin (BSA), had total activity 12-15% of control values; however, in both patient and control samples, freezing/thawing increased leukocyte activity by 25- Mean and range of activity are shown. Total activity, pmol/mg protein/hr; hexosaminidase A, percentage of total activity. Hexosaminidase was assayed with 0.1% bovine serum albumin present. T h e A contribution to total activity was determined by heating the -homogenate a t 50' for 3 hr. Cultured fibroblasts were obtained from leg skin from the patient and foreskin from two neonates. Five paired (patient and control subjects) cultures (3rd to 9th passage) were analyzed after 7-28 days in subculture. BSA: bovine serum albumin, 0.1% (w/v). Cell samples were homogenized in a glass mortar with a Teflon pestle. T h e buffer contained 0.15 M NaCl and 0.01 M potassium phosphate, pH 7.4, with or without BSA. Where indicated, the homogenate was frozen (-70') and thawed (0-4.') seven times before analysis.
50%. Freezinglthawing had little effect on plasma activity. T h e p H versus activity curves for patient and control samples of serum and leukocytes were similar; p H optimum was 4.34.5. Hepatic hexosaminidase activity was <2% of mean control value, and was 83.5% heat denaturable. T h e patient's mother had hexosaminidase activity 42.5% (467 nmol/ml/hr) of mean control activity, with 81% A, in serum; 53.7% (480 nmol/ml/hr), with 72.2% A, in plasma taken 4 months later; and 50.59'0, with 88% hexosaminidase A, in leukocytes.
Hexosaminidase activity of cultured cells was determined between the 3rd and 9th subculture. For both normal and patient fibroblast preparations, with 0.1% BSA in the incubation medium the reaction rates were linear to 30 min and without BSA the rates were nonlinear with time. T h e p H optimum was 4.4 for patient and control fibroblasts. T h e homogenates of cells from the patient, after freezinglthawing, had 7.4% of mean control activity; 95.7% was heat denaturable, compared with 54.5% in control samples (Table IV) .
T h e addition of BSA to the homogenate and omission of freezinglthawing increased mean total activity to 11 % of mean control value (which also rose), but little affected the proportion of hexosaminidase A. Further reduction in the time spent in preparation of cells for assay did not enhance activity. On electrophoresis, control and patient cells showed two bands of activity (Fig.  2) ; heat denaturation reduced the staining intensity of both control bands, particularly the faster one.
T h e fetal calf serum used to support cell growth is rich in hexosaminidase. However, contamination from this source was unlikely with our experimental conditions, in which the A activity of the medium was only 22%. Thus, any such contamination should have enriched the B fraction in fibroblasts from the patient, but this was not observed.
T h e a-and p-galactosidase activities in cultured fibroblasts and preparations of isolated leukocytes from the patient were within normal range. T h e possibility of inhibitors of enzyme activity in patient tissues, or activators in control tissues, was excluded by experiments in which fibroblasts from both sources were mixed in various proportions; substrate hydrolysis rates were as predicted from the measurement of activity in individual fractions.
Although the heat-stable enzyme activity in fibroblasts from the patient was only 5% of total (Table  IV) , compared with 48-57% in control samples, the pattern of activity loss with duration of heating in both was similar (Fig. 3) . T h e patient's cell activity tended to disappear slightly faster when heated, but this difference was significant only at 30 min (P < 0.02).
Hexosaminidase A was partially purified from the patient's plasma, from a control sample (sample I in Table V ) stored at -20" for a similar time, and from a fresh unfrozen sample (sample II). T h e A activity per milligram of protein (based on the amount of heat-denaturable activity in the starting material) was enriched 13-fold in plasma from the patient and 39-and 45-fold in the control samples (recovery of hexosaminidase A was 9.0, 17.6, and 19.296, respectively). Cellulose acetate electrophoresis of the partially purified material from patient and control subjects showed a single band of hexosaminidase activity which corre- sponded to the most rapidly migrating heat-denatuable serum band (A fraction), and their heat clenaturation patterns with 0.1% BSA were similar (Fig. 4 ). An unexpected finding was the relatively large amount of heat-stable material (15.5-22%) in both patient and control samples, particularly as the heat-stable activity in the plasma of the patient was very low (<5% ;   Table 111 ) before purification. Total activity of the partially purified plasma enzyme from patient and control subjects was linear with time to 1 hr with both 4-MU-GlcNAc and GalNAc as substrates; the p H optimum with GlcNAc was 4.04.6, and the curve was broad and flat for patient and control preparations. Variation in substrate concentration revealed a much lower K, and maximal velocity for GalNAc in normal and patient partially purified plasma; with both substrates, the patient's enzyme K, value was sliglltly higher (Table V) and maximal velocity was much lower than that for control subjects.
Apart from the absence of excessive startle response to sound, the clinical presentation in this case resembles that described for Sandhoff's disease [21, 29, 301. Histologically, abnormalities in the tissues available for study were confined to the appendiceal neurones, which were greatly enlarged and contained PAS-staining material in the cytoplasm. Chemical analysis of solid organ tissue was limited to the small sample of liver, precluding extensive study. Less than 25% of the increased dry weight of this sample could be accounted for by increased chloroform-methanol-extractable material; the other >75% may have been stored polysaccharide, as in liver in GM, gangliosidosis type I [48] , and in brain in one reported case of lype 11 [39] , particularly in view of our patient's increased urinary excretion of some polysaccharide component. However, this increase in dry weight must be interpreted cautiously; despite precautions, the sample may have become desiccated during storage. T h e notable findings in the hepatic lipid analysis were increased amounts of a GM,-like ganglioside and of a neutral glycolipid tentatively identified as globoside (Table I1 and Fig.  I ). Globoside accumulation in visceral tissues chemically distinguishes Sandhoff's from Tay-Sachs disease 1291; visceral storage of GM, occurs in both conditions, the absolute amounts varying from case to case [12, 21, 291 . Thus, the clinical, histologic, and chemical features in this case resemble closely those in cases of Sandhoff's disease [21, 29, 391 . Enzyme studies, however, revealed important differences. Using mostly artificial substrates, hexosaminidase activity has been reported to the <5% of control in serum and plasma [3, 10, 12, 21, 451 , and, in two cases, 5Yo and 7.9% of control in whole blood [8] . This activity was reported as predominantly hexosaminidase A, on the basis of heat denaturation and/or electrophoretic separation, but as much as 40% B has been observed [12] . Our patient had 20-24% of normal total activity in plasma and serum, more than 95% heat denaturable; this migrated like the fast, heat-denaturable band in normal serum and therefore was considered to be hexosaminidase A. Mean activity was slightly lower in plasma than in serum, possibly because of heparin inhibition [27] ; in any event, the degree of difference was similar for both patient and control subjects. Leukocyte hexosaminidase activity averaged 10% of control activity, compared with <2% of control in one reported case [391.
I n another case of Sandhoff's disease 11421, hepatic hexosaminidases levels were almost normal during di--phenylhydantoin therapy at toxic doses but were very low after the treatment was stopped, whereas serum enzyme activity remained at 2-5% of normal (80-90% hexosarninidase levels were almost normal during di--was no alteration in plasma or leukocyte hexosaminidase activities in the samples taken after no phenobarbital for 1 week, when serum barbiturate levels had become undetectable. Hexosaminidase activity in the liver biopsy taken at this time, when the possibility of drug effects was minimal, was <2% of normal, including 83.5% heat denaturable, similar to values reported by others.
Fibroblast activity, also, differed from that reported in other cases of Sandhoff's disease. In fibroblasts from our patient, total activity was 7-11% of mean control value (depending on the method of cell preparation for assay), compared with 570 in other studies [3, 21, 231 . Furthermore, Okada et al. [21, 231 reported similar deficiencies in both the A and B fractions, whereas, by heat-denaturation criteria, the enzyme in the fibroblasts from our patient was >95% hexosaminidase A. I t is unlikely that these different heat-denaturation data are attributable to interlaboratory differences in technique, inasmuch as the A proportion in the control fibroblasts in the study by Okada et al. [23] was similar to that in ours.
The number of hexosaminidases in normal human tissues, and their interrelation, is not clear. In serum, two forms (A and B) have been observed by Okada and O'Brien [22] , three by Lowden and LaRamee [14] , and four by Price and Dance [25] ; two types have been detected in leukocytes and cultured fibroblasts [ l l , 23, 381, and two [32, 471 or possibly three types [I21 in liver. Conversion from one form to another by treatment with neuraminidase [6, 181 or by heating [25] has been reported.
In our study, cellulose acetate electrophoresis of control specimens demonstrated three bands of activity in serum and leukocytes and two in fibroblasts: in serum, one band was heat denaturable; in leukocytes, one band was denaturable and another partly so; and in fibroblasts, both bands denatured in part. In the serum, leukocyte, and fibroblast preparations of the patient, the chromatographic behavior of the hexosaminidase activity was similar to that of the heat-denaturable component of the control preparations. The different mobilities of the major bands in both control and patient serum compared with leukocytes and fibroblasts may indicate different species of hexosaminidase in these tissues. However, these findings must be interpreted cautiously. T h e preparations were crude, with widely differing specific activities; therefore, different amounts of protein were spotted for adequate visualization.
T h e partially purified serum enzyme was identified as hexosaminidase A by column chromatographic separation and electrophoretic mobility. Neither patient nor control enzyme preparations heat denatured entirely, despite electrophoretic migration as a single band with mobility similar to the heat-denaturable band of normal serum, and the minimal heat-stable hexosaminidase activity in the patient's plasma from which the purified enzyme was isolated. This may reflect heat-labile to heat-stable conversion of a portion of the partially purified enzyme during manipulation or storage [25] . T h e K, value of the patient's enzyme was slightly higher than control values with both substrates (GalNAc > GlcNAc), which suggested a slight alteration in affinity.
T h e hexosaminidase activities in serum, plasma, and leukocytes of the mother were intermediate between those of the patient and the normal control subjects. This finding, together with the death of at least three related children with an apparently phenotypically similar illness, indicates the inherited nature of this variant. I t is difficult to make a prognosis, but the clinical course of our patient to date, and the history of an apparently similar condition in other members of the kindred, suggest a phenotypic expression similar to that of Sandhoff's and Tay-Sachs disease. T h e different enzyme activities in his vascular compartment and solid tissues support the recent suggestion [3] that enzyme replacement via plasma or blood transfusion may be of little value in the treatment of hexosaminidase deficiencies.
Most studies of hexosaminidases in GM2 gangliosidoses have used the commercially available artificial substrates; hence, our use of these permits direct comparison. It is appreciated, however, that natural substrates, such as GM, ganglioside or globoside, may give different findings; normal activity with artificial substrates, but low activity with natural ones has been reported in Tay-Sachs disease var. AB [31] . Should further tissues from this patient become available, we plan to conduct studies with the natural substrates.
I t has been suggested that the differences in chromatographic and electrophoretic properties of the major forms of hexosaminidases are due to differences in carbohydrate content [6, 181 or indicate that both hexosaminidase A and B are multimers with at least one common subunit and a different subunit [3, 371. T h e latter theory has received strong support recently from immunochemical [26, 361 and cell hybridization studies [43] . Although the structure of the hexosaminidases in man is not known, the enzyme pattern in our patient shows that some degree of A activity alone is possible, analogous to B activity alone in Tay-Sachs disease.
T h e A activity of the patient's cells, however, was not expressed to the same degree in all tissues; it was highest in plasma and serum (2044% of normal), lower in fibroblasts and leukocytes (7-11% of normal), and <2% of normal in liver. T h e liver was frozen before analysis; this could have altered enzyme activity, but any such change probably was slight, inasmuch as plasma and serum activity were unaltered by freezing. Furthermore, when freezinglthawing was omitted and albumin was added for protection, mean fibroblast activity increased from 7% to only 11%. This difference in serum and plasma activity, on the one hand, and liver activity on the other, suggests that the hexosaminidases in serum and plasma differ from those in solid tissues, and that a mutation is possible which can virtually abolish activity in solid tissue but which permits partial activity in serum and plasma. If the latter is derived from the former, by cell turnover and lysosomal enzyme release, our findings suggest that the hexosaminidases may be modified before their entry into the vascular compartment. Such a modification could permit partial restoration of activity to an inactive enzyme. I n our case, the phenotypic expression of the disease, and the storage of material in appendiceal neurones, indicate that activity may be very low in brain as well as in liver. T h e reverse situation, absent hexosaminidase A activity in the serum, with a normal phenotype (and therefore presumably normal activity in brain), has been reported [19, 461 , and severe deficiency of galactose l-phosphate uridyltransferase in blood but normal activity in liver has been described in apparently healthy adults [34] .
Summary
A 28-month-old Negro male with clinical, histologic, and chemical findings closely resembling those of Sandhoff's disease is described. Hexosaminidase activity, however, showed important differences: in serum and plasma, total hexosaminidase (> 95% hexosaminidase A) was 20 to 24% of normal, compared with <5% of normal in other reported cases, but in liver, as in other cases, total hexosaminidase was <2% of normal.
This case appears to represent a "new" variant of Sandhoff's disease.
